Abstract
In order to elucidate the reason for conflicting results that have been published previously on galectin-3 expression in human gliomas, we used single labeling and double labeling immunohistochemistry experiments to identify cellular origin and extent of galectin-3 positivity in 53 glioma-samples (16 glioblastomas, 21 anaplastic astrocytomas, 16 low-grade astrocytomas). Galectin-3 positivity was observed in neoplastic astrocytes, macrophages/microglial cells, endothelial cells and some B- and T-lymphocytes. The quantitative analysis showed that the percentage of galectin-3 positive cells was significantly higher in the tumor parenchyma of glioblastomas than in anaplastic (p = 0.0371) and low-grade astrocytomas (p = 0.0042). Single labeling with anti-CD68 antibodies revealed a significant correlation between CD68 and galectin-3 immunoreactivity (p = 0.0092). Endothelial cells were labeled in all low-grade and anaplastic astrocytomas, but only in 10/16 glioblastomas (p = 0.0003). This detailed analysis demonstrates that galectin-3 positivity in human gliomas is considerably influenced by tumor-infiltrating macrophages. The differential expression on endothelial cells raises the question if galectin-3 plays a role in tumor angiogenesis of human gliomas.
Similar content being viewed by others
References
Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A: Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80: 776–787, 1997
Gordower L, Decaestecker Y, Kacem Y, Lemmers J, Gusman J, Burchert M, Danguy A, Gabius HJ, Salmon R, Camby I: Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropath Appl Neurobiol 25: 319–330, 1999
Akimoto Y, Hirabayashi J, Kasai K, Hirano H: Expression of the endogenous 14-kDa beta-galactoside-binding lectin galectin in normal human skin. Cell Tissue Res 280: 1–10, 1995
Sanford GL, Harris HS: Stimulation of vascular cell proliferation by beta-galactoside specific lectins. FASEB J 4: 2912–2918, 1990
Dagher SF, Wang JL, Patterson RJ: Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA 92: 1213–1217, 1995
Kuwabara I, Liu FT: Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156: 3939–3944, 1996
Yang RY, Hsu DK, Liu FT: Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93: 6737–6742, 1996
Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson-WR J: Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 147: 1016–1028, 1995
Bao Q, Hughes RC: Galectin-3 expression and effects on cyst enlargement and tubulogenesis in kidney epithelial MDCK cells cultured in three-dimensional matrices in vitro. J Cell Sci 108: 2791–2800, 1995
Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC, Nicolson GL: Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconj J 11: 462–468, 1994
Gaudin JC, Arar C, Monsigny M, Legrand A: Modulation of the expression of the rabbit galectin-3 gene by p53 and c-Ha-ras proteins and PMA. Glycobiology 7: 1089–1098, 1997
Raz A, Zhu DG, Hogan V, Shah N, Raz T, Karkash R, Pazerini G, Carmi P: Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 46: 871–877, 1990
Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia MP, Raz A: Metastasis of human colon cancer is altered by modifying expression of the betagalactoside-binding protein galectin 3. Gastroenterology 115: 287–296, 1998
Xu XC, El-Naggar AK, Lotan R: Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147: 815–822, 1995
Castronovo V, Van-Den-Brule FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME: Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179: 43–48, 1996
Lotz MM, Andrews-CW J, Korzelius CA, Lee EC, Steele-GD J, Clarke A, Mercurio AM: Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90: 3466–3470, 1993
Schoeppner HL, Raz A, Ho SB, Bresalier RS: Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75: 2818–2826, 1995
Roggendorf W, Strupp S, Paulus W: Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92: 288–293, 1996
Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T: Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res 59: 722–730, 2000
Strik H, Deininger M, Streffer J, Grote E, Wickboldt J, Dichgans J, Weller M, Meyermann R: Bcl-2 family protein expression in initial and recurrent glioblastomas: Modulation by radiochemotherapy. J Neurol Neurosurg Psych 67: 763–768, 1999
Roth W, Grimmel C, Rieger L, Strik H, Takayama S, Krajewski S, Meyermann R, Dichgans J, Reed JC, Weller M: Bag-1 and Bcl-2 gene transfer in malignant glioma: Modulation of cell cycle regulation and apoptosis. Brain Path 10: 223–234, 2000
Perillo NL, Pace KE, Seilhamer JJ, Baum LG, Sato S, Hughes RC: Apoptosis of T cells mediated by galectin-1. Nature 378: 736–739, 1995
Weller M, Fontana A: The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Rev 21: 128–151, 1995
Camby I, Belot, Rorive S, Lefranc F, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotchi J, Zick Y, Salmon I, Gabius HJ, Kiss R: Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 11: 12–26, 2001
Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neuro-oncol 32: 253–265, 1997
Nangia MP, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156: 899–909, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strik, H.M., Deininger, M.H., Frank, B. et al. Galectin-3: Cellular Distribution and Correlation with WHO-grade in Human Gliomas. J Neurooncol 53, 13–20 (2001). https://doi.org/10.1023/A:1011874800612
Issue Date:
DOI: https://doi.org/10.1023/A:1011874800612